Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Profiles of Globotriaosylsphingosine Analogs and Globotriaosylceramide Isoforms Accumulated in Body Fluids from Various Phenotypic Fabry Patients.

Internal medicine (Tokyo, Japan) - 1 Jun 2024

Shiga Tomoko, Tsukimura Takahiro, Kubota Takao, Togawa Tadayasu, Sakuraba Hitoshi

Abstract excerpt

Objectives Fabry disease is characterized by the systemic accumulation of globotriaosylceramide (Gb3) and globotriaosylsphingosine (Lyso-Gb3), which are widely used as biomarkers of the disease. However, few reports have described the relationship of Lyso-Gb3 analogs and Gb3 isoforms with the disease. The present study determined the profiles of Lyso-Gb3 analogs and Gb3 isoforms accumulated in body fluids from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Galactosidase
Share to Body Fluids

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enzyme Replacement Therapy

Share to Fabry Disease

Share to Glycolipids

Share to Sphingolipids

Share to Tandem Mass Spectrometry

Share to Trihexosylceramides

Source

Open in PubMed Open full text

Identifiers

PMID: 37866916
DOI: 10.2169/internalmedicine.2493-23
PMCID: PMC11189715

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Profiles of Globotriaosylsphingosine Analogs and Globotriaosylceramide Isoforms Accumulated in Body Fluids from Various Phenotypic Fabry Patients.PMID 37866916Read ↗

Nano-LC-MS/MS for Quantification of Lyso-Gb3 and Its Analogues Reveals a Useful Biomarker for Fabry Disease.Semantic proximity Read ↗

Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort.Semantic proximity Read ↗

Biomarkers in Anderson–Fabry DiseaseSemantic proximity Read ↗

Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease.Semantic proximity Read ↗

Metabolic progression to clinical phenotype in classic Fabry disease.Semantic proximity Read ↗

Variations in the GLA gene correlate with globotriaosylceramide and globotriaosylsphingosine analog levels in urine and plasma.Semantic proximity Read ↗

Fabry Disease: Molecular Basis, Pathophysiology, Diagnostics and Potential Therapeutic Directions.Semantic proximity Read ↗

Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease.Semantic proximity Read ↗

Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.Semantic proximity Read ↗

LysoGb3 quantification facilitates phenotypic categorization of Fabry disease patients: Insights gained by a novel MS/MS method.Semantic proximity Read ↗

The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levels.Semantic proximity Read ↗

Precision medicine in Fabry disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.